363 related articles for article (PubMed ID: 32023919)
1. TLR4-Targeting Therapeutics: Structural Basis and Computer-Aided Drug Discovery Approaches.
Ain QU; Batool M; Choi S
Molecules; 2020 Jan; 25(3):. PubMed ID: 32023919
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
Mishra V; Pathak C
J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
[TBL] [Abstract][Full Text] [Related]
3. Computational Approaches to Toll-Like Receptor 4 Modulation.
Billod JM; Lacetera A; Guzmán-Caldentey J; Martín-Santamaría S
Molecules; 2016 Jul; 21(8):. PubMed ID: 27483231
[TBL] [Abstract][Full Text] [Related]
4. Application of
Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R
Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002
[TBL] [Abstract][Full Text] [Related]
5. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
6. An in silico approach towards the identification of novel inhibitors of the TLR-4 signaling pathway.
Mahita J; Harini K; Rao Pichika M; Sowdhamini R
J Biomol Struct Dyn; 2016 Jun; 34(6):1345-62. PubMed ID: 26264972
[TBL] [Abstract][Full Text] [Related]
7. Advances in Drug Discovery and Design using Computer-aided Molecular Modeling.
Singh K; Bhushan B; Singh B
Curr Comput Aided Drug Des; 2024; 20(5):697-710. PubMed ID: 37711101
[TBL] [Abstract][Full Text] [Related]
8. Modern Computational Strategies for Designing Drugs to Curb Human Diseases: A Prospect.
Dar KB; Bhat AH; Amin S; Hamid R; Anees S; Anjum S; Reshi BA; Zargar MA; Masood A; Ganie SA
Curr Top Med Chem; 2018; 18(31):2702-2719. PubMed ID: 30659543
[TBL] [Abstract][Full Text] [Related]
9. Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview.
Romerio A; Peri F
Front Immunol; 2020; 11():1210. PubMed ID: 32765484
[TBL] [Abstract][Full Text] [Related]
10. Rational Drug Design of Antineoplastic Agents Using 3D-QSAR, Cheminformatic, and Virtual Screening Approaches.
Vucicevic J; Nikolic K; Mitchell JBO
Curr Med Chem; 2019; 26(21):3874-3889. PubMed ID: 28707592
[TBL] [Abstract][Full Text] [Related]
11. Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process.
Hasan MR; Alsaiari AA; Fakhurji BZ; Molla MHR; Asseri AH; Sumon MAA; Park MN; Ahammad F; Kim B
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807415
[TBL] [Abstract][Full Text] [Related]
12. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
13. Balancing Inflammation: Computational Design of Small-Molecule Toll-like Receptor Modulators.
Murgueitio MS; Rakers C; Frank A; Wolber G
Trends Pharmacol Sci; 2017 Feb; 38(2):155-168. PubMed ID: 27863853
[TBL] [Abstract][Full Text] [Related]
14. Computer-aided Drug Design and Drug Pharmacokinetic Prediction: A Mini-review.
Tabeshpour J; Sahebkar A; Zirak MR; Zeinali M; Hashemzaei M; Rakhshani S; Rakhshani S
Curr Pharm Des; 2018; 24(26):3014-3019. PubMed ID: 30179125
[TBL] [Abstract][Full Text] [Related]
15. Computer Aided Drug Design Studies in the Discovery of Secondary Metabolites Targeted Against Age-Related Neurodegenerative Diseases.
Scotti L; Scotti MT
Curr Top Med Chem; 2015; 15(21):2239-52. PubMed ID: 26059353
[TBL] [Abstract][Full Text] [Related]
16. Computer Aided Drug Design for Multi-Target Drug Design: SAR /QSAR, Molecular Docking and Pharmacophore Methods.
Abdolmaleki A; Ghasemi JB; Ghasemi F
Curr Drug Targets; 2017; 18(5):556-575. PubMed ID: 26721410
[TBL] [Abstract][Full Text] [Related]
17. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
Rodríguez D; Gutiérrez-de-Terán H
Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
[TBL] [Abstract][Full Text] [Related]
18. Computational Insight Into the Structural Organization of Full-Length Toll-Like Receptor 4 Dimer in a Model Phospholipid Bilayer.
Patra MC; Kwon HK; Batool M; Choi S
Front Immunol; 2018; 9():489. PubMed ID: 29593733
[TBL] [Abstract][Full Text] [Related]
19. Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer.
Mishra V; Pathak C
Int J Biol Macromol; 2019 Feb; 122():425-451. PubMed ID: 30365988
[TBL] [Abstract][Full Text] [Related]
20. Proposing novel TNFα direct inhibitor Scaffolds using fragment-docking based e-pharmacophore modeling and binary QSAR-based virtual screening protocols pipeline.
Zaka M; Abbasi BH; Durdagi S
J Mol Graph Model; 2018 Oct; 85():111-121. PubMed ID: 30149308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
